← Leaderboards
Jagath Junutula
Cellerant Therapeutics, Inc.
$1,496,276
Attributed
$1,496,276
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,496,276 · 1
By mechanism
N44$1,496,276 · 1
Top collaborators
No co-investigators on record.
Most similar at Cellerant Therapeutics, Inc.
Same institution · by research overlap
- Holger Karsunky$3,179,282
- Ramkumar K Mandalam$2,045,696
- Adrianus G.w. Domen$658,973
- David C Scherer$100,000
- Swapna Panuganti$558,580
Others in their field
Top investigators on “Affinity”
- Dennis R. Burton · Scripps Research Institute$64,397,776
- James E Crowe · Vanderbilt University Medical Center$53,471,415
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$45,445,140
- Timothy A Springer · Boston Children'S Hospital$41,593,445
- Misty Ward Stevens · Intervexion Therapeutics, Llc$38,187,594
- Rafi Ahmed · Emory University$36,776,987
Research focus
AffinityAntibodiesBaseBindingCancer Stem CellCell GrowthCellsContractorContractsEffectivenessHematopoietic Stem CellsHuman TissueLeadMembraneNeoplastic CellNonhuman PrimateNovel TherapeuticsPharmaceutical PreparationsPropertyResearch StudyRodentSmall Business Innovation Research GrantStem Cell LeukemiaSurvival Rate